a phase ii trial of pembrolizumab for richter's transformation of cll
Published 1 month ago • 114 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
2:05
in-vivo modeling of cll and richter's transformation
-
5:13
phase ii trial of pembrolizumab prior to allo-sct in aml
-
0:34
advice for community physicians managing richter's transformation of cll
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
3:02
euplagia-1: phase i trial of glpg5201, a cd19 car-t product, in r/r cll and richter's transformation
-
![[online seminar] new holladay report for best results in iol calculations & refractive surgery](https://i.ytimg.com/vi/6lV2600PL14/mqdefault.jpg)
1:03:27
[online seminar] new holladay report for best results in iol calculations & refractive surgery
-
23:23
identifying and treating high-risk patients in 2023
-
14:21
3mensio ct pre-case planning: valve-in-valve tavr in mosaic
-
1:09
early results from epcore cll-1 trial: subcutaneous epcoritamab in patients with richter’s syndrome
-
0:36
risk factors for richter’s transformation in cll
-
2:08
phase ii trial of nivolumab combined with ibrutinib for patients with richter transformation
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:22
advances in our understanding of the factors contributing to richter’s transformation in cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
1:37
u2' regimen with checkpoint inhibition in r/r cll and richter's transformation
-
1:15
the role of transplant in cll and richter's transformation today
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
2:38
ibrutinib treatment for cll does not increase the incidence of richter’s transformation
-
1:28
overview of resonate-2 clinical trial of ibrutinib in cll
-
1:27
cll patient-derived xenografts recapitulate clonal evolution of richter transformation
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
1:26
overview of the resonate-2 clinical trial of ibrutinib as front-line therapy